PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.63%
Revenue growth 1.25-1.5x MDB's 6.38%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
6.06%
Gross profit growth above 1.5x MDB's 3.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
4.87%
Positive EBIT growth while MDB is negative. John Neff might see a substantial edge in operational management.
4.87%
Positive operating income growth while MDB is negative. John Neff might view this as a competitive edge in operations.
9.45%
Positive net income growth while MDB is negative. John Neff might see a big relative performance advantage.
7.14%
Positive EPS growth while MDB is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
7.14%
Positive diluted EPS growth while MDB is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.88%
Share count expansion well above MDB's 0.93%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.88%
Diluted share count expanding well above MDB's 0.93%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
24.20%
Positive OCF growth while MDB is negative. John Neff would see this as a clear operational advantage vs. the competitor.
27.27%
Positive FCF growth while MDB is negative. John Neff would see a strong competitive edge in net cash generation.
-26.87%
Negative 10Y revenue/share CAGR while MDB stands at 121.40%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-26.87%
Negative 5Y CAGR while MDB stands at 511.24%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-26.87%
Negative 3Y CAGR while MDB stands at 148.86%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
60.31%
10Y OCF/share CAGR above 1.5x MDB's 36.31%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
60.31%
Positive OCF/share growth while MDB is negative. John Neff might see a comparative advantage in operational cash viability.
60.31%
Positive 3Y OCF/share CAGR while MDB is negative. John Neff might see a big short-term edge in operational efficiency.
1.38%
Below 50% of MDB's 13.95%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1.38%
Positive 5Y CAGR while MDB is negative. John Neff might view this as a strong mid-term relative advantage.
1.38%
Positive short-term CAGR while MDB is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.79%
Firm’s AR is declining while MDB shows 29.34%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.99%
Inventory is declining while MDB stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.03%
Negative asset growth while MDB invests at 0.70%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.83%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.00%
We’re deleveraging while MDB stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
2.10%
R&D dropping or stable vs. MDB's 12.10%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.53%
SG&A declining or stable vs. MDB's 18.94%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.